Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $123.3500 (0.36%) ($121.0500 - $125.6800) on Wed. Oct. 21, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 39 | Latest Price | $123.3500(0.36%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(48%) XBI(46%) XLV(45%) IWO(38%) VYM(38%) | Factors Impacting UTHR price | UTHR will decline at least -1.165% in a week (0% probabilities). VIXM(-19%) TLT(-15%) BNDX(-5%) UUP(-4%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
Resistance Level | $127.86 | 5 Day Moving Average | $125.83(-1.97%) | 10 Day Moving Average | $124.68(-1.07%) | 20 Day Moving Average | $127.86(-3.53%) | To recent high | -26.8% | To recent low | 0.9% | Market Cap | $5.471b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |